Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
PrECOG, LLC.
Alliance for Clinical Trials in Oncology
University of Maryland, Baltimore
NRG Oncology
Big Ten Cancer Research Consortium
Mayo Clinic
Weill Medical College of Cornell University
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Fundación GECP
Massachusetts General Hospital
Sichuan University
Spanish Lung Cancer Group
Sichuan University
Spanish Lung Cancer Group
Nanfang Hospital, Southern Medical University
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fudan University
University of Washington
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Swiss Cancer Institute
University of California, San Francisco
Sun Yat-sen University
Chonnam National University Hospital
Swiss Cancer Institute
RTOG Foundation, Inc.
Duke University
UNICANCER
Fuzhou General Hospital
Abramson Cancer Center at Penn Medicine
University of California, San Diego
Zhejiang Cancer Hospital
Leo W. Jenkins Cancer Center
Swiss Cancer Institute
Swiss Cancer Institute
Swiss Cancer Institute
Swiss Cancer Institute
Guangdong Association of Clinical Trials
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
West China Hospital